Table 1.
Demographics, baseline characteristics and outcome of hospitalized patients with COVID-19 categorized in cancer, and without cancer subgroups, N=92796
|
Non cancer
patients n=91464 (%) |
Cancer patients
n=1332 (%) |
Total | Chi-Square | P value | OR (CI95%) | |
|---|---|---|---|---|---|---|
| Age Mean (± SD), Median (Q1, Q3) |
49.96 (18.08) 49 (37,63) |
51.74 (22.8) 57 (40, 68) |
49.98 (18.16) 50 (37,63) |
67761252.5 | <0.0001 | - |
| Sex | ||||||
| Male | 46649 (51.1) | 652 (48.9) | 47301 (51) | 2.216a | 0.137 | 1.08 (0.97-1.21) |
| Female | 44815 (48.9) | 680 (51.1) | 45495 (49) | |||
| Fever (yes) | 34345 (37.6) | 612 (45.9) | 34957 (37.7) | 39.413a | <0.0001 | 1.41 (1.26-1.57) |
| Cough | 58823 (64.3) | 841 (63.1) | 59664 (64.3) | 0.789a | 0.374 | 0.95 (0.85-1.06) |
| Myalgia | 34086 (37.3) | 531 (39.9) | 34617 (37.3) | 3.788a | 0.052 | 1.11 (0.99-1.24) |
| Dyspnea | 46898 (51.3) | 668 (50.2) | 47566 (51.3) | .665a | 0.415 | 0.95 (0.85-1.06) |
| Loss of consciousness | 2877 (3.1) | 133 (10) | 3010 (3.2) | 195.684a | <0.0001 | 3.41 (2.84-4.1) |
| Loss of Smell | 1136 (1.2) | 14 (1.1) | 1150 (1.2) | 0.391a | 0.532 | 0.84 (0.49-1.43) |
| Loss of Taste | 1014 (1.1) | 10 (0.8) | 1024 (1.1) | 1.541a | 0.214 | 0.67 (0.36-1.26) |
| Seizure | 285 (0.3) | 6 (0.5) | 291 (0.3) | 0.810a | 0.368 | 1.44 (0.64-3.25) |
| Abdominal pain | 1316 (1.4) | 42 (3.2) | 1358 (1.5) | 26.840a | <0.0001 | 2.23 (1.63-3.05) |
| Nausea | 5684 (6.2) | 182 (13.7) | 5866 (6.3) | 123.413a | <0.0001 | 2.39 (2.04-2.8) |
| Vomit | 3819 (4.2) | 100 (7.5) | 3919 (4.2) | 36.184a | <0.0001 | 1.86 (1.51-2.29) |
| Diarrhea | 2316 (2.5) | 50 (3.8) | 2366 (2.6) | 7.932a | 0.005 | 1.5 (1.13-2) |
| Loss of appetite | 12333 (13.5) | 396 (29.8) | 12729 | 293.736a | <0.0001 | 2.72 (2.41-3.06) |
| Headache | 9513 (10.4) | 181 (13.6) | 9694 (10.5) | 14.376a | <0.0001 | 1.35 (1.15-1.58) |
| Dizziness | 3729 (41) | 58 (4.4) | 3787 (4.1) | .266a | 0.606 | 1.07 (0.82-1.39) |
| Paresis of limbs | 291 (0.3) | 5 (0.4) | 296 (0.3) | 0.137a | 0.711 | 1.18 (0.48-2.86) |
| Paralysis of limbs | 158 (0.2) | 2 (0.2) | 160 (0.2) | 0.845 | 1 | 0.87 (0.21-3.51) |
| Chest pain | 3009 (3.3) | 35 (2.6) | 3044 (3.3) | 1.798a | 0.180 | 0.79 (0.56-1.11) |
| skin rash | 107 (0.1) | 3 (0.2) | 110 (0.1) | 1.303a | 0.254 | 1.92 (0.61-6.08) |
| PO2 saturation scale | ||||||
| Upper 93 percent | 69885 (76.4) | 913 (68.5) | 70798 | 44.887a | <0.0001 | 1.48 (1.32-1.67) |
| Under 93 percent | 21579 (23.6) | 419 (31.5) | 21998 | |||
| Current smoker | 739 (0.8) | 23 (1.7) | 762 (0.8) | 13.608a | <0.0001 | 2.15 (1.41-3.27) |
| Drug use | 385 (0.4) | 16 (1.2) | 401(.4) | 18.577a | <0.0001 | 2.87 (1.73-4.75) |
| Chronic liver disease |
260 (0.3) | 15 (1.1) | 275 (0.3) | 31.610a | <0.0001 | 4 (2.37-6.75) |
| Diabetic | 14507 (15.9) | 225 (16.9) | 14732 (15.9) | 1.121a | 0.290 | 1.08 (0.93-1.24) |
| Hematologic disorders |
375 (0.4) | 83 (6.2) | 458 (0.5) | 908.207a | <0.0001 | 16.18 (12.67-20.65) |
| HIV/AIDS | 62 (0.1) | 2 (0.2) | 64 (0.1) | 1.300a | 0.254 | 2.22 (0.54-9.09) |
| Autoimmune disorders |
204 (0.2) | 8 (0.6) | 212 (0.2) | 8.251a | 0.004 | 2.7 (1.33-5.5) |
| Pregnancy | 1161 (1.3) | 2 (0.2) | 1163 (1.3) | 13.250a | <0.0001 | 0.11 (0.02-0.47) |
| Heart disease | 7932 (8.7) | 131 (9.9) | 8063 (8.7) | 2.318a | 0.128 | 1.15 (0.96-1.38) |
| HTN | 13494 (14.8) | 226 (17) | 13720 (14.8) | 5.272a | 0.022 | 1.18 (1.02-1.36) |
| Chronic Kidney disease |
1592 (1.7) | 39 (2.9) | 1631 (1.8) | 10.814a | 0.001 | 1.7 (1.23-2.35) |
| Dialysis | 728 (45.7) | 14 (35.9) | 742 (45.5) | 1.484a | .223 | 0.66 (0.34-1.28) |
| Asthma | 1755 (1.9) | 8 (0.6) | 1763 (1.9) | 12.187a | <0.0001 | 0.31 (0.15-0.62) |
| Other chronic respiratory disorders |
675 (0.7) | 22 (1.7) | 697 (0.8) | 14.788a | <0.0001 | 2.26 (1.47-3.47) |
| Diseases of the nervous system |
686 (0.8) | 11 (0.8) | 697 (0.8) | 0.106a | 0.745 | 1.1 (0.6-2) |